Viking Therapeutics (VKTX) had the highest return between February 1, 2023 and June 20, 2023 by a mid-cap US stock, returning 147.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Viking Therapeutics (VKTX) | 2/1/2023 - 6/20/2023 | 147.56% |
Oscar Health (OSCR) | 2/1/2023 - 6/20/2023 | 131.33% |
MoonLake Immunotherapeutics (MLTX) | 2/1/2023 - 6/20/2023 | 121.26% |
Arlington Asset Investment (AI) | 2/1/2023 - 6/20/2023 | 116.17% |
IONQ (IONQ) | 2/1/2023 - 6/20/2023 | 109.21% |
Vita Coco (COCO) | 2/1/2023 - 6/20/2023 | 104.85% |
Protagonist Therapeutics (PTGX) | 2/1/2023 - 6/20/2023 | 103.24% |
SoundHound AI (SOUN) | 2/1/2023 - 6/20/2023 | 98.41% |
Iris Energy (IREN) | 2/1/2023 - 6/20/2023 | 92.56% |
SkyWest (SKYW) | 2/1/2023 - 6/20/2023 | 90.75% |
ELF Beauty (ELF) | 2/1/2023 - 6/20/2023 | 86.77% |
ACV Auctions (ACVA) | 2/1/2023 - 6/20/2023 | 82.96% |
Upstart Holdings (UPST) | 2/1/2023 - 6/20/2023 | 81.86% |
Riot Blockchain (RIOT) | 2/1/2023 - 6/20/2023 | 80.29% |
Green Brick Partners (GRBK) | 2/1/2023 - 6/20/2023 | 77.94% |
BridgeBio Pharma (BBIO) | 2/1/2023 - 6/20/2023 | 77.44% |
Lifestance Health (LFST) | 2/1/2023 - 6/20/2023 | 74.62% |
Merus (MRUS) | 2/1/2023 - 6/20/2023 | 69.96% |
Soleno Therapeutics (SLNO) | 2/1/2023 - 6/20/2023 | 68.62% |
Apellis Pharmaceuticals (APLS) | 2/1/2023 - 6/20/2023 | 67.57% |
Intapp (INTA) | 2/1/2023 - 6/20/2023 | 67.31% |
Joby Aviation (JOBY) | 2/1/2023 - 6/20/2023 | 66.51% |
Enel Chile SA ADR (ENIC) | 2/1/2023 - 6/20/2023 | 64.54% |
Stevanato Group SpA (STVN) | 2/1/2023 - 6/20/2023 | 64.23% |
VEON (VEON) | 2/1/2023 - 6/20/2023 | 63.39% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
